Article Text

Download PDFPDF
Epoprostenol for severe pulmonary hypertension

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Average survival time with untreated idiopathic pulmonary hypertension is 2.8 years in adults and 10 months in children. Successful treatment with epoprostenol (prostacyclin) was reported for adults in 1996 and for children in 1999. Now a report from the Great Ormond Street Hospital for Children, London (Heart, published …

View Full Text